Interactions between filamin a and MMP-9 regulate proliferation and invasion in renal cell carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 8, 2014, Pages 3789-3795

  Sun, Guo Gui ^a   Wei, Cui Da ^b   Jing, Shao Wu ^c   Hu, Wan Ning ^a  

^a Department of Chemoradiotherapy   (China)

^b Tangshan Worker's Hospital   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

FLNA; Immunohistochemical analysis; MMP 9; Renal cell carcinoma

Indexed keywords

FILAMIN; FLNA PROTEIN, HUMAN; GELATINASE B; MMP9 PROTEIN, HUMAN;

ADULT; AGED; CELL CYCLE; CELL PROLIFERATION; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING; YOUNG ADULT;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FILAMINS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; YOUNG ADULT;

EID: 84901992325     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.8.3789     Document Type: Article

References (25)

1. Ai J, Huang H, Lv X, et al (2011). FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma. Cell Physiol Biochem, 27, 207-16.
2. Bourguignon LY, Gilad E, Peyrollier K (2007). Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. J Biol Chem, 282, 19426-41.
3. Bedolla RG, Wang Y, Asuncion A, et al (2009). Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res, 15, 788-96.
4. Cairns P (2011). Renal cell carcinoma. Cancer Biomarkers, 9, 461-73.
5. Feng Y, Walsh CA (2004). The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol, 6, 1034-8.
6. He HJ, Kole S, Kwon YK, et al (2003). Interaction of filamin A with the insulin receptor alters insulin-dependent activation of the mitogen-activated protein kinase pathway. J Biol Chem, 278, 27096-104.
7. Roberson SP, Twigg SR, Sutherland-Smith AJ, et al (2003). OPD-spectrum Disorders Clinical Collaborative Group. Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diversem alform at ions in humans. Nat Gene, 33, 487-91.
8. Keshamouni VG, Michailidis G, Grasso CS, et al (2006). Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/ invasive phenotype. J Proteome Res, 5, 1143- 54.
9. Ljungberg B, Campbell SC, Cho HY, et al (2011). The epidemiology of renal carcinoma. Eur Urol, 60, 615-21.
10. Nakamura F, Osborn TM, Hartemink CA, et al (2007). Structure basis of filamin A functions. J Cell Biol, 179, 1011-25.
11. Onoprishvili I, Ali S, Andria ML, et al (2008). Filamin A mutant lacking actin-binding domain restores mu opioid receptor regulation in melanoma cells. Neurochem Res, 33, 2054-61.
12. Tan X, He S, Han Y, et al (2013). Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients. Cancer Cell Int, 13, 20.
13. Stossel TP, Condeelis J, Cooley L, et al (2001). Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol, 2, 138-45.
14. Sheen VL, Feng Y, Graham D, et al (2002). Filamin A and Filamin B are co-expressed within neurons during periods of neuronal migration and can physically interact. Hum Mol Genet, 11, 2845-54.
15. Stadler WM, Figlin RA, McDermott DF, et al (2010). ARCCS Study Investigators: Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America. Cancer, 116, 1272-80.
16. Shi JW, Yu YM, Wang SJ, et al (2010). Expressions of filamin A and matrix metalloproteinase 9 in colorectal adenocarcinoma and their significance. Tumor, 30, 768-773.
17. Sun GG, Hu WN, Wang YD, et al (2012). Bidirectional Regulation of manganese superoxide dismutase (MnSOD) on the radiosensitivity of esophageal cancer cells. Asian Pac J Cancer Prev, 13, 3015-23.
18. Sun GG, Wang YD, Lu YF, et al (2013). Different association of manganese superoxide dismutase gene polymorphisms with risk of prostate, esophageal, and lung cancers: evidence from a meta-analysis of 20, 025 subjects. Asian Pac J Cancer Prev, 14, 1937-43.
19. Wu YP, Li JB, Zhao RJ, et al (2009). Expression of filam in A in invasive breast carcinoma and its significance. Tumor, 29, 659-62.
20. Watanabe H (2010). Extracellular matrix-regulationof cancer invasion and metastasis. Gan ToKagaku Ryoho, 37, 2058-61.
21. Yang S, Du J, Wang Z (2007). BMP-6 promotes E-cadherin expression through repressing delta EF1 in breast cancer cells. BMC Cancer, 7, 211.
22. Yu HB, Zhang HF, Li DY, et al (2011) . Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. J Asian Nat Prod Res, 13, 242-50.
23. Zhu TN, He HJ, Kole S, et al (2007). Filamin A-mediated down-regulation of the exchange factor Ras-GRF1 correlates with decreased matrix metalloproteinase-9 expression in human melanoma cells. J Biol Chem, 282, 14816-26.
24. Zhou X, Boren J, Akyurek LM, (2007). Filamins in cardiovascular development. Trends Cardiovasc Med, 17, 222-9.
25. Zhang M, Zhu GY, Gao HY, et al (2011). Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell adenocarcinoma. J Surg Oncol, 103, 243-7.